Clinical Trials Sponsored by Korea Cancer Center Hospital

Total 10169 results

Fujian Cancer Hospital

Not yet recruiting

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Small Cell Lung Cancer | Chemotherapy Effect | Angiogenesis
Fujian Cancer Hospital

Not yet recruiting

Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain

Hawthorn Red Combined Refractory Cancer Pain
Zhejiang Cancer Hospital

Recruiting

GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence (GOT)

Intrahepatic Cholangiocarcinoma

China
Henan Cancer Hospital

Not yet recruiting

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Hepatocellular Carcinoma
Zhejiang Cancer Hospital

Recruiting

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Locally Advanced Gastric Cancer

China
Zhejiang Cancer Hospital

Recruiting

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Nasopharyngeal Carcinoma

China
Henan Cancer Hospital

Recruiting

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Desmoid

China
Zhejiang Cancer Hospital

Not yet recruiting

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study

Histologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis
Henan Cancer Hospital

Recruiting

Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors

Clinical Features | Bone and Soft Tissue Tumors

China
Henan Cancer Hospital

Recruiting

PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma

Advanced Melanoma

China
Henan Cancer Hospital

Recruiting

Study on Clinical Features, Treatment Mode and Survival of Sarcoma

Sarcoma

China
Fujian Cancer Hospital

Not yet recruiting

To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer

Colon Cancer
Hunan Cancer Hospital

Recruiting

Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

Breast Neoplasms | Neoplastic Cells, Circulating | Chemotherapy Effect

China
Fujian Cancer Hospital

Recruiting

Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab

Gastric Cancer Stage IV

China
Henan Cancer Hospital

Recruiting

Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer

SCLC, Extensive Stage

China
Zhejiang Cancer Hospital

Recruiting

Retrospective Study of Brachytherapy (RetroBT)

Uterine Cervical Neoplasms | Uterine Neoplasms | Ovarian Neoplasms | Vulvar Cancer | Vaginal Cancer | Brachytherapy | Gynecologic Neoplasm

China
Fujian Cancer Hospital

Recruiting

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Immunotherapy | Gastrict Cancer

China
Henan Cancer Hospital

Not yet recruiting

PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma. (SCRCA)

Cholangiocarcinoma
Henan Cancer Hospital

Recruiting

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Soft Tissue Sarcoma

China
Zhejiang Cancer Hospital

Recruiting

Dendrobium Huoshanense Suppository in Rectal Cancer

Locally Advanced Rectal Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Fujian Cancer Hospital

Not yet recruiting

Effects of Mobile Medicine on Cancer Patients

Cancer Pain
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma

Advanced Gastric Carcinoma

China
Henan Cancer Hospital

Recruiting

Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma

Central Nervous System Lymphoma

China
Zhejiang Cancer Hospital

Recruiting

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Malignant Tumor

China
Fujian Cancer Hospital

Not yet recruiting

Second-line Surufatinib Combined With Chemotherapy in Advanced CRC

Advanced Colorectal Cancer
Fujian Cancer Hospital

Not yet recruiting

Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy

NSCLC Stage IV

China
Henan Cancer Hospital

Recruiting

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Marginal Zone Lymphoma

China
Zhejiang Cancer Hospital

Recruiting

The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma

Pancreatic Cancer

China
Zhejiang Cancer Hospital

Recruiting

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Brain Metastases | NSCLC Stage IV | Immunotherapy

China
Henan Cancer Hospital

Recruiting

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

Lymphoma | Gene Abnormality

China
Zhejiang Cancer Hospital

Recruiting

Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study

Gastric Adenocarcinoma

China
Henan Cancer Hospital

Recruiting

Study of CT and MR in the Gastric Cancer

MRI | Neoadjuvant Therapy | Gastric Cancer Stage | CT

China
Henan Cancer Hospital

Recruiting

Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer

Esophageal Cancer | Squamous Cell Carcinoma | Perioperative Period

China
Zhejiang Cancer Hospital

Recruiting

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

Head and Neck Neoplasms

China
Henan Cancer Hospital

Recruiting

The Application of 3T MRI in Esophageal Cancer

Magnetic Resonance Imaging | Prognosis | Esophageal Cancer TNM Staging

China
Henan Cancer Hospital

Completed

Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

Triple Negative Breast Cancer

China
Henan Cancer Hospital

Active, not recruiting

SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer

China
Hubei Cancer Hospital

Enrolling by invitation

Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery

Breast Neoplasm Female

China
Zhejiang Cancer Hospital

Completed

HFNC and Hypoxia/Desaturation During Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical Trial

Hypoxia | Propofol | Sedation Complication | Desaturation of Blood

China
Zhejiang Cancer Hospital

Active, not recruiting

A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure

Epithelial Ovarian Cancer

China
Zhejiang Cancer Hospital

Completed

Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery

Breast Cancer

China
Zhejiang Cancer Hospital

Completed

The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery

Ovarian Neoplasm Epithelial
Hunan Cancer Hospital

Completed

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Metastatic Colorectal Adenocarcinoma

China
Hunan Cancer Hospital

Completed

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer

Colorectal Cancer

China
Fujian Cancer Hospital

Active, not recruiting

A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01). (ERI-Based-01)

Breast Cancer

China
Hunan Cancer Hospital

Completed

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Metastatic Colorectal Adenocarcinoma

China
Hunan Cancer Hospital

Completed

Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Adenocarcinoma

China
Barretos Cancer Hospital

Completed

Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical Prostatectomy

Prostate Cancer

Brazil
Barretos Cancer Hospital

Completed

Neoadjuvant Carboplatin in Triple Negative Breast Cancer

BRCA1 Hereditary Breast and Ovarian Cancer Syndrome

Brazil

3

Subscribe